presents the following three events:
Title: “Pushing the Limits: Being Innovative in a Regulated Industry”
Date: Thursday, November 15th
Time: Registration & Networking at 5:30PM, Educational session begins at 6:30 PM
Venue: Alnylam in Cambridge, MA
Description: Join the ISPE Boston Area Chapter for an open forum on innovation. Push your own limits by participating in our pre-program activity with pharma colleagues while enjoying refreshments and a cash bar. Please have valid I. D. ready for a security checkpoint. Walk-ins are still welcome to register onsite.
Event website: https://www.ispeboston.org/events/?eventID=841
Title: “Bridging the Gap in Gender Diversity”
Date: Tuesday, December 4th
Time: 6:00 PM – 8:00 PM
Venue: Alexion in Boston, MA (Seaport District)
Description: This discussion on the current state and positive actions for gender diversity would be valuable for all levels of leaders from all functions in the Life Sciences sector. The Women in Pharma group of the Boston Area Chapter of ISPE is particularly focused on women in technical roles in manufacturing and engineering which are areas with historically larger than typical gender diversity gaps compared to other functions in the Life Sciences sector.
Event website: https://www.ispeboston.org/events/?eventID=974
Title: “Designing, Building & Operating Manufacturing Facilities for Novel Therapeutics”
Date: Thursday, December 6th
Time: Registration & Networking at 5:30PM, Educational session begins at 6:30 PM
Venue: Novartis Institutes for Biomedical Reach in Cambridge, MA
Description: Join us for an interactive panel discussion that will offer access to experts from leading firms in the gene & cell therapy space, prominent CDMO’s and a principal process engineer. Enjoy refreshments and the company of colleagues and friends prior to the educational session.
Event website: https://www.ispeboston.org/events/?eventID=843
The ISPE Boston Area Chapter is comprised of members from regional life sciences companies as well as service providers and equipment manufacturers that support these manufacturing and research operations. Student members of ISPE attend educational programs free of charge.
BioEntrepreneur Bootcamp & Pitch Contest 2018
presented by MassBio & SR One
November 27, 2018
8:00 AM – 5:00 PM
300 Technology Square, Cambridge, MA
Join us for a one-day crash course in entrepreneurship:
Hear from industry experts how to employ the essential elements of a successful startup
Polish your pitch for the chance to win multiple prizes
Whether you are an established entrepreneur or are inspired to become one, this program will fill the knowledge gap to provide attendees with actionable steps to take their innovations forward. This full-day event will feature panels, fireside chats, and an audience pitch contest, concluding with a networking reception.
Apply to Envision Conference 2018!
Envision Conference explores how to build a brighter future through the prudent advancement of breakthrough technologies. Our 3rd annual conference will be held November 30 - December 2, 2018 at Princeton University.
The Envision Conference includes three tracks: Natural Sciences, Computer Science, and Humanities & Social Sciences. In each domain we will introduce the ethics of technology to future leaders. These tracks will teach participants to make prudent decisions throughout their careers in developing/using technologies that pose an existential threat.
In addition to Envision’s usual focus on technical domains, our new Humanities track will allow participants to identify problems that could arise from social and cultural interactions mediated by technology.
Students will get to learn about all three tracks through panels, workshops, and other events that will engage participants and provide strategies on the best way forward. Our current speakers include Peter Singer, Vincent Conitzer and Wendell Wallach. Visit our website for more information.
The deadline for the regular application is November 4th at 11:59 pm. Undergraduate and graduate students encouraged to apply.
Let’s pioneer a brighter future, today.
The Envision Team
Pioneering a brighter future, today
Focuses on the implications of artificial intelligence, enhanced interfaces, nanotechnology, and synthetic biology.
Investigates catastrophic and existential risk, material advancement, space development, economic/social change, and human enhancement.
Previous sponsors included Microsoft, SAS, SpaceX, Prudential and Kernel.
Last year’s participants included Hackathon-winning undergrads, widely published PhDs, student group founders, and technically competent students from 67 different universities, including all top American schools.
The Ethical and Legal Considerations of
Consumer Genetic Technologies
Conference Date: May 17, 2019
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is pleased to announce plans for our 2019 annual conference: “Consuming Genetics: The Ethical and Legal Considerations of Consumer Genetic Technologies.” This year’s conference is organized in collaboration with Nita A. Farahany, Duke Law School, and Henry T. Greely, Stanford Law School.
Breakthroughs in genetics have often raised complex ethical and legal questions. Many regard their genetic testing and sequencing as revealing something intensely personal and private. The questions raised by these technologies loom even larger as genetic testing is becoming more commonplace, affordable, and comprehensive. At the same time, advances in CRISPR and other related technologies raise anxieties about the implications of editing our own DNA. One can imagine a future when gene editing may become as widespread as genetic testing is today. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing. This conference will examine some of these issues.
The rise of genetic testing has allowed individuals to gain new insights into their unique makeup. Already the global genetic testing and consumer/wellness genomics market was valued at $2.24 billion in 2015 and is expected to double by 2025. Amazon noted that Ancestry.com’s DNA test kit was one of their best-selling products on cyber Monday of 2018. The availability of these technologies inspires patients to act proactively to avoid medical conditions, such as when actress Angelina Jolie pursued a double mastectomy after genetic testing revealed that she was in the highest risk category for developing breast and ovarian cancers. The rise of direct-to-consumer genetic testing kits raises questions about the appropriate setting for these activities, however. For example, the Food and Drug Administration expressed concern about 23 and Me’s initial product offering, noting that delivering health-related results directly to consumers might cause these individuals to draw the wrong medical conclusions.
The increased ease of genetic testing and sequencing has also led to a sharp increase in genetic data and the rise of precision medicine. The rise of genetic databases raises significant ethical questions, especially around privacy concerns. In an age where serial killers are caught because their relatives chose to submit DNA to a consumer genealogy database, is genetic privacy for individuals possible? The economics here are significant. Consider the increased value of Myriad’s database of variances of unknown significance after the Supreme Court in Association for Molecular Pathology v. Myriad Genetics held that isolated genes cannot be patented. Does the aggregation of data from genetic testing turn people into products by commercializing their data? How might this data reduce or exacerbate already significant health care disparities?
While gene editing tools such as CRISPR are not yet as widely available as genetic testing technology, in some parts of the world their availability is already spreading. There have been reports that Chinese scientists have used CRISPR-Cas9 technology to genetically engineer the cells of at least 86 patients. Companies in the United States and Europe are expected to begin treating patients with CRISPR-based therapies this year. Many countries have drawn a line against germline modification, but this prohibition may be strained if gene editing technology is widely disseminated. Before we reach that point, this is the time to consider what ethical and regulatory safeguards should be implemented for when the time comes.
To learn more, visit our website!
New England Venture Summit
December 12, 2018
Lombardo’s Conference Center, Boston, MA
Where Innovation Meets Capital
Come meet, interact and network with more than 700 VCs, Corporate VCs, angel investors, investment bankers and founders of venture backed, emerging and early stage companies at the prestigious New England Venture Summit being held on December 12th 2018 at Lombardo’s in Boston Randolph, MA.
Whether you’re a startup seeking capital and exposure, or an investor seeking new deals, The New England Venture Summit presented by youngStartup Ventures - is the event of the year you won't want to miss.
A highly productive venture conference, The New England Venture Summit is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage companies.
Initial lineup of VCs confirmed to speak and judge includes:
Magdi Amin, Investment Partner, Omidyar Network | Janet Bannister, Partner, Real Ventures | Peter Bastien, Partner, Next47 | Joshua Berg, Investment Manager, GM Ventures | Dan Burstein, Managing Partner, Millennium Technology Value Partners | Meghan Cross Breeden, Managing Partner, Red Bear Angels | David Cruikshank, Partner, ARCH Venture Partners | Miriam Eaves, Venture Partner, BP Ventures | Michael Fanfant, Investor, Runa Capital | Mark G. Fields, Partner, Alsop Louie Partners | Prashant Fonseka, Principal, Tuesday Capital | Matt Gatto, Partner, Insight Venture Partners | Stephen Gilfus, Founder, Blackboard Inc. | Jamil Goheer, Managing Partner & Cofounder, CoVenture | Jacob E. Grose, Investment Manager, BASF Venture Capital | Marina Hadjipateras, Co-Founder & General Partner, Trail Mix Ventures | Mar Hershenson, Co-Founding Managing Partner, Pear Ventures | Noel Jee, Investor, Illumina Ventures | Jamie Kasuboski, Senior Director , Boehringer Ingelheim Venture Fund | Patrick Kenealy, Managing Director, Ridge Ventures | Daniel Kwak, Investor, Point72 Ventures | Kyle Lui, Principal, DCM Ventures | Hiroki Matsuda, Investor, Sozo Ventures | David Miller, Co-Founder and Managing Director, Clean Energy Ventures | Kirsten Morbeck, Managing Director, SpringRock Ventures | Amit Mulgaonkar, Investor, Mithril Capital Management | Brian Panoff, Senior Principal, Shell Ventures | Sumay Parikh, Principal, Quake Capital | Vinny Pujji, Investor, Insight Venture Partners | Wanda Reindorf, Managing Director, Clean Energy Ventures | Praveen Sahay, Managing Director, WAVE Equity Partners | Louis Schick, Founding Partner, NewWorld Capital Group | Connie Sheng, Founding Managing Partner, Nautilus Venture Partners | Alex Shtarkman, Associate, Revolution Ventures | Laurel Touby, Partner, Supernode Ventures | Claude Vachet, Managing Partner, Cycle Capital Management | Maria Velissaris, Investor, Pipeline Angels | Geeta Vemuri, Managing Partner, Agent Capital | John Wei, Sr. Investment Manager, SABIC Ventures | Jamie M. Weston, Managing Director, Spring Mountain Capital | Troy Williams, Managing Director, University Ventures | Lu Zhang, Founder & Managing Partner, Fusion Fund and many more.
Harvard Biotech Club has made special arrangement for our network to receive a special discount of 10% off the existing “early bird" savings.
This conference will be attended by the best people in the industry. Please register early to avoid disappointment.
Register Today & Save Click here. (Use promo code "HBCVIP”)
In addition to providing access to leading Investors, the conference will feature more than 50 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking.
Call for TOP INNOVATORS!
Get Noticed > Get Funded > Grow Faster
A select group of more than 50 Top Innovators from the Technology, Life Sciences/Healthcare, CleanTech and Fintech sectors will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.
Apply to Present / Nominate a company:
For more information or to be considered for one of the Top Innovator slots click here.
If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for our Seed stage track.
We look forward to seeing you there.
ANNOUCEMENTS + POSTINGS:
If you have biotech or healthcare related news/events/jobs that you would like us to advertise, please email
HBC.email@example.com with concise event information (format: Title, date, time, venue, description, contact info/event website) in text form. Please do not only send us a flyer! Please send us material at least 3 weeks in advance so we can include your event on the bi-weekly bulletin.